Advertisement
YOU ARE HERE: LAT HomeCollectionsGlucose Levels
IN THE NEWS

Glucose Levels

SCIENCE
October 24, 2009 | Shari Roan
A medication that is under review by the Food and Drug Administration for the treatment of type 2 diabetes may also promote weight loss, according to a study published online Thursday in the Lancet. The drug, liraglutide, was approved earlier this year in Europe for the treatment of diabetes. It is marketed under the brand name Victoza. Liraglutide is an injected drug that stimulates the release of insulin when glucose levels become too high. It also helps curb appetite. In the new study, researchers in Denmark assigned 564 obese people to one of four liraglutide doses, a placebo or the weight-loss drug orlistat.
Advertisement
NEWS
August 9, 1992
As an Hispanic who has been recently diagnosed with diabetes mellitus, I read your article ("Minority Groups at Risk of Diabetes," July 21) with interest. I am currently enrolled in a research study at Harbor-UCLA Medical Center, Division of Endocrinology and Metabolism, that is investigating the effects of the drug glipizide on the blood-glucose levels in minorities. Through education received here, I have learned that with proper diet, medication, exercise, constant personal monitoring of my blood-sugar levels, and most of all, attitude adjustment, I will live a productive life.
NEWS
August 12, 1993 | Associated Press
Diabetics who have been barred from driving trucks or buses across state lines will be allowed to operate the vehicles if they meet stringent conditions, the federal government announced Wednesday. The Federal Highway Administration said insulin-using diabetics who qualify will be given waivers to drive the vehicles in interstate commerce for three years while the agency seeks to develop a permanent rule.
BUSINESS
March 14, 2006 | From the Associated Press
Abbott Laboratories said Monday that it had received approval from the Food and Drug Administration for a new blood glucose monitoring system -- an announcement that came as its stock rose to a six-month high. The go-ahead added to Abbott's momentum after the release of positive results from the first trial of its ZoMaxx device, a drug-coated stent intended to unclog arteries to the heart, Sunday at the American College of Cardiology's annual meeting in Atlanta.
CALIFORNIA | LOCAL
July 1, 1998
UCLA was awarded a $3.5-million grant Tuesday to study how the brain responds to traumatic injury. The five-year grant from the National Institutes of Neurological Disorders and Stroke will fund a collaborative study by the Division of Neurosurgery and the Department of Molecular and Medical Pharmacology. "There is a traumatic brain injury occurring once every 10 seconds in the United States," said Donald Becker, chief of neurosurgery.
NEWS
March 2, 2011 | By Thomas H. Maugh II, Los Angeles Times
A 50-year-old with Type 2 diabetes will lose an average of six years of life as a result of the disease, only one less than would be lost by a long-term smoker of the same age, researchers reported Wednesday. He or she is more than twice as likely to die of cardiovascular disease as someone without diabetes and 25% more likely to die of cancer, according to the report, an international study of more than 820,000 people published in the New England Journal of Medicine. People with Type 2 diabetes are also more likely to die from kidney disease, liver disease, pneumonia, infectious diseases and even intentional self-harm, according to the study, which was conducted by the Emerging Risk Factors Collaboration, based at the University of Cambridge in England.
HEALTH
November 15, 2004 | Melissa Healy, Times Staff Writer
All right, it's not the fountain of youth. But a study published in the Nov. 10 issue of the Journal of the American Medical Assn. has found that DHEA, a hormone widely marketed as a nutritional supplement, decreases belly fat and improves the body's use of insulin among the elderly when taken daily for six months. Earlier studies have shown that DHEA supplementation led to improved bone density and an enhanced sense of well-being. "We were surprised that there was such an effect," said Dr.
HEALTH
March 3, 2011 | By Thomas H. Maugh II, Los Angeles Times
A 50-year-old with Type 2 diabetes will lose an average of six years of life as a result of the disease, only one less than would be lost by a long-term smoker of the same age, researchers reported Wednesday. He or she is more than twice as likely to die of cardiovascular disease as someone without diabetes and 25% more likely to die of cancer, according to the report, an international study of more than 820,000 people published in the New England Journal of Medicine. People with Type 2 diabetes are also more likely to die from kidney disease, liver disease, pneumonia, infectious diseases and even intentional self-harm, according to the study, which was conducted by the Emerging Risk Factors Collaboration, based at the University of Cambridge in England.
NEWS
February 13, 1991 | ROBERT STEINBROOK, TIMES MEDICAL WRITER
A strict diet and medication changes begun before a diabetic woman becomes pregnant significantly reduce her chance of giving birth to a baby with serious birth defects, according to a new study by UC San Francisco researchers. Most diabetic women of childbearing age are unaware of this advice and only 5% to 10% are seeking medical care before they become pregnant, said Dr. John L. Kitzmiller, a UC San Francisco professor and principal author of the study.
NEWS
February 2, 1990 | JANNY SCOTT, TIMES MEDICAL WRITER
The health benefits of using olive oil instead of butter may extend beyond controlling cholesterol, according to a study published today that suggests olive oil may also help hold down blood pressure and glucose in the blood. The study, in the Journal of the American Medical Assn., comes at a time of growing interest in the advantages of so-called monounsaturated fats. Some researchers suspect that those oils may prove more useful than vegetable oils in preventing heart disease.
Los Angeles Times Articles
|